Related references
Note: Only part of the references are listed.Muller cells as a target for retinal therapy
Joke Devoldere et al.
DRUG DISCOVERY TODAY (2019)
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease
Gaia Faustini et al.
ACTA NEUROPATHOLOGICA (2018)
Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina
D. G. Hickey et al.
GENE THERAPY (2017)
Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
Jeffrey S. Heier et al.
LANCET (2017)
Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations
William A. Beltran et al.
MOLECULAR THERAPY (2017)
First AAV gene therapy poised for landmark approval
Eric Smalley
NATURE BIOTECHNOLOGY (2017)
AAV5-Factor VIII Gene Transfer in Severe Hemophilia A
Savita Rangarajan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial
Agnieszka Ciesielska et al.
PLOS ONE (2017)
Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation Trial
Ian J. Constable et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial
Nicola G. Ghazi et al.
HUMAN GENETICS (2016)
Adeno-associated virus (AAV) vectors in cancer gene therapy
Jorge L. Santiago-Ortiz et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Visual Acuity after Retinal Gene Therapy for Choroideremia
Thomas L. Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Retinoschisin gene therapy in photoreceptors, Muller glia or all retinal cells in the Rs1h-/- mouse
L. C. Byrne et al.
GENE THERAPY (2014)
AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer
Yi Xie et al.
GYNECOLOGIC ONCOLOGY (2014)
Specific tools for targeting and expression in Muller glial cells
Lucie P. Pellissier et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
AAV-Mediated, Optogenetic Ablation of Muller Glia Leads to Structural and Functional Changes in the Mouse Retina
Leah C. Byrne et al.
PLOS ONE (2013)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Gene therapy rescues cone function in congenital achromatopsia
Andras M. Komaromy et al.
HUMAN MOLECULAR GENETICS (2010)
GFAP-Driven GFP Expression in Activated Mouse Muller Glial Cells Aligning Retinal Blood Vessels Following Intravitreal Injection of AAV2/6 Vectors
Wendy M. Aartsen et al.
PLOS ONE (2010)
Molecular Evolution of Adeno-associated Virus for Enhanced Glial Gene Delivery
James T. Koerber et al.
MOLECULAR THERAPY (2009)
A Novel Adeno-Associated Viral Variant for Efficient and Selective Intravitreal Transduction of Rat Muller Cells
Ryan R. Klimczak et al.
PLOS ONE (2009)
Gene Therapy Using Adeno-Associated Virus Vectors
Shyam Daya et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9
Bassel Akache et al.
JOURNAL OF VIROLOGY (2006)
α2,3 and α2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6
Zhijian Wu et al.
JOURNAL OF VIROLOGY (2006)
Receptor targeting of adeno-associated virus vectors
H Büning et al.
GENE THERAPY (2003)
High-affinity GABA uptake in retinal glial (Muller) cells of the guinea pig: Electrophysiological characterization, immunohistochemical localization, and modeling of efficiency
B Biedermann et al.
GLIA (2002)
Share Paper
